These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Sioussat TM; Dvorak HF; Brock TA; Senger DR Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657 [TBL] [Abstract][Full Text] [Related]
3. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Brock TA; Dvorak HF; Senger DR Am J Pathol; 1991 Jan; 138(1):213-21. PubMed ID: 1987767 [TBL] [Abstract][Full Text] [Related]
4. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Senger DR; Connolly DT; Van de Water L; Feder J; Dvorak HF Cancer Res; 1990 Mar; 50(6):1774-8. PubMed ID: 2155059 [TBL] [Abstract][Full Text] [Related]
5. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. Dvorak HF; Sioussat TM; Brown LF; Berse B; Nagy JA; Sotrel A; Manseau EJ; Van de Water L; Senger DR J Exp Med; 1991 Nov; 174(5):1275-8. PubMed ID: 1940805 [TBL] [Abstract][Full Text] [Related]
6. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172 [TBL] [Abstract][Full Text] [Related]
7. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
8. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. Criscuolo GR; Lelkes PI; Rotrosen D; Oldfield EH J Neurosurg; 1989 Dec; 71(6):884-91. PubMed ID: 2585081 [TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702 [TBL] [Abstract][Full Text] [Related]
11. Specific binding of vascular permeability factor to endothelial cells. Olander JV; Connolly DT; DeLarco JE Biochem Biophys Res Commun; 1991 Feb; 175(1):68-76. PubMed ID: 1998521 [TBL] [Abstract][Full Text] [Related]
12. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Shen H; Clauss M; Ryan J; Schmidt AM; Tijburg P; Borden L; Connolly D; Stern D; Kao J Blood; 1993 May; 81(10):2767-73. PubMed ID: 8490183 [TBL] [Abstract][Full Text] [Related]